Japan-headquartered Atonarp has raised $50 million from a Series D funding round led by Silicon Valley-based investor WRVI Capital and supported by Furukawa Electric, Japan Post Investment, Boscolo ...
Pictor Labs, a leader in AI-powered virtual staining and digital pathology innovation, today announced the launch of ClearStain™, its latest advancement designed to revolutionize molecular diagnostic ...
Molecular diagnostics firm BillionToOne raised $273.1 million in its U.S. initial public offering on Wednesday, pricing its shares above its marketed range.
New York, October 07, 2021 – Reports and Data has published its latest report titled “In-Vitro Diagnostics (IVD) Quality Control Market, By Product & Service Type (Quality Control Products, Whole ...
The company's Dragonfly instrument uses a proprietary sample preparation method and isothermal amplification to diagnose a variety of infectious diseases.
In vitro diagnostics (IVD) is an umbrella term for tests conducted on blood or tissue samples to detect diseases, determine the efficacy of novel or established treatments, and monitor health.
Former lab director of Hong Kong Molecular Pathology Diagnostic Centre awarded contract at community testing centre to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback